Prevalence of hepatitis C and its risk factors in blood donors at Shiraz transfusion center

Koomesh

Volumn 10, Issue 1, 2008, Pages

  Kasraian, Leila ^a   Tavassoli, Alireza ^b  

^a Education Ward of Fars Blood Transfusion Organization   (Iran)

^b Shiraz Blood Transfusion Organization   (Iran)

Author keywords

Blood donors; HCV; Prevalence; Risk factor

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DONOR SELECTION; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX; VIRUS TRANSMISSION;

EID: 77449110995     PISSN: 16087046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tong MJ, EI-Farra NS, Reikes AR, and Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl Med 1995; 332: 1463-1466.
2. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, and Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
3. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, and et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450-456.
4. World Health Organization .global prevalence Hepatitis C. Weekly Epidemiology Rev 1997;72:341-344.
5. Mast EE, Alter MJ, and Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17: 1730-1733.
6. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, and et al. The preval-ence of hepatitis C virus infection in the United States, 1988 through 1994. New England J Med 1999; 341:556-562.
7. Mutimer DJ, Harrison RF, O'Donnell KB, Shaw J, Martin BA, Atrah H, and et al. Hepatitis C virus infection in the asymptomatic Blood donors. J Viral Hepat 1995; 2: 47-53.
8. Sulaiman HA, Julitasari, Sie A, Rustam M, Melani W, Corwin A, and Jennings GB. Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Tran R Soc Trop Med Hyg 1995; 89: 167-170.
9. Songsivilai S, Jinathongthai S, Wongsena W, Tiangpitayakorn C, and Dharakul T. High prevalence of hepatitis C infection among blood donors in northeastern Thailand. Am J Trop Med Hyg 1997; 57: 66-69.
10. Arthur RR, Hassan NF, Abdallah MY, el-Sharkawy MS, Saad MD, Hackbart BG, and Imam IZ. Hepatitis C antibody prevalence in blood donors in different governrates in Egypt. Tran R Soc Trop Med Hyg 1997; 91: 271-274.
11. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepatitis 1999;6:35-47.
12. Hatami H, and Malekzadeh R. Reagent and emergent Infectionous. Disease and Health of Medical Staff 2003; 2: 589-594.
13. Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995;15: 5-14.
14. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ and et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997; 119: 349-356.
15. Bari A, Akhtar S, Rahbar MH, and Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi Islamabad, Pakistan. Trop Med Int Health 2001; 6: 732-738.
16. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, and et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000; 78: 956-963.
17. Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP. Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Epidemiol Infect 2003; 130: 293-300.
18. Pasha O, Luby SP, Khan AJ, Shah AS, McCormick JB, Fisher-Hoch SP. Household members of hepatitis C virus infected people in Hafizabad, Pakistan: infections by injections from health care providers. Epidemiol Infect 1999; 123: 515-518.
19. Akhtar S. Moatter T, Rahbar MH, Azam I, Saman A. prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. Pakistan. J Viral Hepat 2002; 9:309-314.
20. S. Akhtar, M. Younus M, Adil S, Jafri SH, and Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi Pakistan. J Viral Hepat 2004; 11: 527-535.
21. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C, Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia. Transfusion 1994; 34: 135- 137.
22. Patino-Sarcinelli F, Hyman J, Camacho LAB, Linhares DB, Azevedo JG. Prevalence and risk factors for hepatitis C antibodies in volunteer blood donors in Brazil. Transfusion 1994; 34: 138-141.
23. Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, and et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group. Vox sang 1990, 59: 26-29
24. Wang B, Schreiber GB, Glynn SA, Nass CC, Smith JW, Higgins MJ, and et al. Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site. Transfusion 2003; 43: 705-712.
25. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, and et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284:229-350.
26. Brandão AB, and Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case control study. BMC Gastroenterol 2002; 2: 18.
27. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, and et al. Estimates of infectious disease risk factors in US blood donors.Retrovirus Epidemiology Donor Study. JAMA 1997, 277: 967-972
28. Kasraian L, and Torab jahromi SA. Survey of the Frequency of People Who Have Donated Blood for HIV Check up At Shiraz Blood Transfusion Organization. J Kurdistan Med Sci Uni 2005; 10: 36-41 (Persian).
29. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, and Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: result of case-control study. Gastroenterology 1999; 116, 893-899.
30. Neal KR, Jones DA, Killey D and James V. Risk factors for hepatitis C virus infection. a case-control study of blood donors in the Trent Region [UK). Epidemiol Infect 1994; 112: 595-601.
31. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, and et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231-2235.
32. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L and et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996, 334: 1691-1696.
33. Shev S, Hemodsson S, Lindholm A, Malm E, Widell A, and Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors - the role of parenteral and sexual transmission. Scand J Infect Dis 1995, 27: 99-104.
34. Guerrero-Romero JF, Castaneda A, and Rodriguez-Moran M. Prevalence of risk factors associated with hepatitis C in blood donors in the municipality of Durango, Mexico. Salud publica Mex 1996, 38: 94-100.
35. Eyster ME, Alter HJ, Aledort LM, Quan S, Hatzakis A, and Goedert JJ. Heterosexual co-transmission of hepatitis C virus([HCV) and human immunodeficiency virus (HIV). Ann Intern med 1991; 115: 764-768.
36. Tong MJ, Lai PPC, Hwang SJ, Lee SY, Co RL, Chien RN, and Kuo G. Evaluation of sexual transmission in patients with chronic hepatitis C infection. Clin Diag Virol 1995; 3: 39-47.